Top Headline
CVS Caremark CVS reported a 25 percent rise in its third-quarter earnings and lifted its earnings forecast for the year.
CVS Caremark's quarterly profit surged to $1.25 billion, or $1.02 per share, versus a year-ago profit of $1.01 billion, or $0.79 per share. Excluding one-time items, its adjusted earnings came in at $1.05 per share. The company had earlier expected earnings of $1 to $1.03 per share. Its revenue rose 5.8 percent to $32 billion, versus analysts' estimates of $31.53 billion.
Equities Trading UPEndo Health Solutions ENDP shot up 29.63 percent to $55.58 after the company announced its plans to acquire Paladin Labs for $1.6 billion in stock and cash.
Shares of GT Advanced Technologies GTAT got a boost, shooting up 20.29 percent to $10.07 following Monday's announcement of deal with Apple for sapphire materials.
Marvell Technology MRVL was also up, gaining 9.74 percent to $13.18 after KKR KKR announced it had acquired a stake in the company.Equities Trading DOWN
Shares of Orbitz Worldwide OWW fell 19.00 percent Tuesday to $7.76 after the company reported an earnings miss and lowered its third quarter revenue guidance before the open, crushing its momentum from last week.
Polypore International PPO was down, falling 14.80 percent to $37.40 on Q3 results.
CommoditiesIn commodity news, oil traded down 1.38 percent to $93.31, while gold traded down 0.31 percent to $1,310.50.
Silver traded up 0.16 percent Tuesday to $21.69, while copper rose 0.29 percent to $3.26.
EurozoneEuropean shares were lower today. The Spanish Ibex Index fell 0.72 percent, while Italy's FTSE MIB Index dropped 1.13 percent. Meanwhile, the German DAX declined 0.38 percent and the French CAC 40 tumbled 0.82 percent while U.K. shares fell 0.37 percent.
Economics
The ISM non-manufacturing index rose to 55.40 in October, from a prior reading of 54.40. However, economists were expecting a reading of 54.00.
The ICSC-Goldman Sachs store sales index declined 0.6 percent in the week ending Saturday versus the earlier week.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.